NDC 63323-285-55 - Naropin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 63323-285
Requested NDC: 63323-285-55
Package NDCs from labels: 63323-285-41, 63323-285-28, 63323-285-53, 63323-285-68, 63323-285-59, 63323-285-73, 63323-285-01, 63323-285-10, 63323-285-06, 63323-285-20, 63323-285-03, 63323-285-13, 63323-285-07, 63323-285-23, 63323-285-57, 63323-285-64, 63323-285-51, 63323-285-65, 63323-285-02, 63323-285-61, 63323-285-04, 63323-285-63, 63323-285-55, 63323-285-67
Manufacturer: Fresenius Kabi USA, LLC
Effective date: 2024-08-15
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Naropin - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2024-08-15	HUMAN PRESCRIPTION DRUG LABEL
Naropin - Fresenius Kabi USA, LLC \| Fresenius Kabi Austria \| HP Halden Pharma AS	Fresenius Kabi USA, LLC \| Fresenius Kabi Austria \| HP Halden Pharma AS	2024-08-06	HUMAN PRESCRIPTION DRUG LABEL
Naropin - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2024-07-10	HUMAN PRESCRIPTION DRUG LABEL
Naropin - APP Pharmaceuticals, LLC \| Fresenius Kabi Norge AS	APP Pharmaceuticals, LLC \| Fresenius Kabi Norge AS	2011-09-15	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63323-285-01	Naropin	10 mL in 1 AMPULE	INJECTION, SOLUTION	10	27
63323-285-02	Naropin	100 mL in 1 BAG	INJECTION, SOLUTION	100	27
63323-285-03	Naropin	10 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	10	27
63323-285-04	Naropin	200 mL in 1 BAG	INJECTION, SOLUTION	200	27
63323-285-06	Naropin	20 mL in 1 AMPULE	INJECTION, SOLUTION	20	27
63323-285-07	Naropin	20 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	20	27
63323-285-10	Naropin	5 in 1 BOX	INJECTION, SOLUTION	5	27
63323-285-13	Naropin	25 in 1 CARTON	INJECTION, SOLUTION	25	27
63323-285-20	Naropin	5 in 1 BOX	INJECTION, SOLUTION	5	27
63323-285-23	Naropin	25 in 1 CARTON	INJECTION, SOLUTION	25	27
63323-285-51	Naropin	100 mL in 1 BOTTLE	INJECTION, SOLUTION	100	27
63323-285-57	Naropin	200 mL in 1 BOTTLE	INJECTION, SOLUTION	200	27
63323-285-61	Naropin	24 in 1 CASE	INJECTION, SOLUTION	24	27
63323-285-63	Naropin	24 in 1 CASE	INJECTION, SOLUTION	24	27
63323-285-64	Naropin	12 in 1 CASE	INJECTION, SOLUTION	12	27
63323-285-65	Naropin	12 in 1 CASE	INJECTION, SOLUTION	12	27
63323-285-55	Naropin	100 mL in 1 BOTTLE	INJECTION, SOLUTION	100	8
63323-285-67	Naropin	12 in 1 CASE	INJECTION, SOLUTION	12	8
63323-285-28	Naropin	25 in 1 CARTON	INJECTION, SOLUTION	25	6
63323-285-41	Naropin	20 mL in 1 VIAL, SINGLE-USE	INJECTION, SOLUTION	20	6
63323-285-53	Naropin	100 mL in 1 BOTTLE	INJECTION, SOLUTION	100	6
63323-285-59	Naropin	200 mL in 1 BOTTLE	INJECTION, SOLUTION	200	6
63323-285-68	Naropin	12 in 1 CASE	INJECTION, SOLUTION	12	6
63323-285-73	Naropin	12 in 1 CASE	INJECTION, SOLUTION	12	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-285	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]	27	Current NDC, Legacy NDC, 16 package rows	20240814_23d2d448-a744-4877-9f2d-7e57c198da89.zip
63323-285	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]	8	Current NDC, Legacy NDC, 2 package rows	20240817_c6613708-c1f7-4f5c-91a3-ebbc1d7905c6.zip
63323-285	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]	6	Current NDC, Legacy NDC, 6 package rows	20240829_dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-285-01	ML - Milliliter	63323-285	893d30d3-b6d5-462c-bc51-8cbf1886c255	1	2021-09-07
63323-285-02	ML - Milliliter	63323-285	9bdc252f-940e-4528-8b2b-4da77d9ecc3a	1	2021-09-07
63323-285-03	ML - Milliliter	63323-285	da85634f-61af-4b22-a40e-ba62d9a6edad	1	2024-05-16
63323-285-04	ML - Milliliter	63323-285	81a7042a-f052-49fa-b262-8d24da6883c4	1	2025-09-12
63323-285-06	ML - Milliliter	63323-285	d741087a-35e2-410e-b6f6-83dd30872f57	1	2021-10-08
63323-285-07	ML - Milliliter	63323-285	89f2db61-bda6-46e6-b177-6bc7a355a88c	1	2019-12-10
63323-285-10	ML - Milliliter	63323-285	a00fb96b-a729-4e34-9f7c-df4846da95cd	1	2012-07-24
63323-285-13	ML - Milliliter	63323-285	37cc6a92-bef0-483c-b9a3-f4151a5c6ea8	1	2013-02-13
63323-285-20	ML - Milliliter	63323-285	ee701e17-d341-42b2-98fd-4132ce75af29	1	2012-07-24
63323-285-23	ML - Milliliter	63323-285	80084105-4a41-47e9-b0eb-642c4886b0ce	1	2013-02-13
63323-285-28	ML - Milliliter	63323-285	00d04aec-77b7-47e9-af8a-c646c87ae741	1	2013-12-02
63323-285-41	ML - Milliliter	63323-285	97920a89-34e5-4b22-96ee-46acd0c8cbc8	1	2024-07-12
63323-285-61	ML - Milliliter	63323-285	9ced10cb-e20a-4f51-9c40-0bb690ae40d6	1	2014-12-01
63323-285-63	ML - Milliliter	63323-285	bf1577aa-f242-4c8a-af89-6e0799cf40aa	1	2014-12-01
63323-285-64	ML - Milliliter	63323-285	5c072df3-66ab-48c5-b8a2-1466693b4f17	1	2012-07-24
63323-285-65	ML - Milliliter	63323-285	e2abc321-1532-41d0-886c-bf58d34a7d13	1	2012-07-24
63323-285-67	ML - Milliliter	63323-285	782ee9c8-c46c-428f-9158-37e1f61cf8a2	1	2012-07-24
63323-285-68	ML - Milliliter	63323-285	e3bc0528-9df1-4dbc-8c8a-81e01f68c8bb	1	2013-12-02
63323-285-73	ML - Milliliter	63323-285	87b770ee-12e2-482b-ba6c-566687bea3e1	1	2014-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ROPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V910P86109	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	14
ROPIVACAINE	ACTIVE MOIETY	7IO5LYA57N	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	14
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	14
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	14
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	14
ROPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V910P86109	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]	4
ROPIVACAINE	ACTIVE MOIETY	7IO5LYA57N	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]	4
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]	4
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]	4
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]	4
ROPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V910P86109	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3
ROPIVACAINE	ACTIVE MOIETY	7IO5LYA57N	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3
ROPIVACAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V910P86109	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
ROPIVACAINE	ACTIVE MOIETY	7IO5LYA57N	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 29 of 44 · 865 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Naropin	ROPIVACAINE HYDROCHLORIDE	Fresenius Kabi USA, LLC	23d2d448-a744-4877-9f2d-7e57c198da89	2024-08-06	Warnings, Adverse reactions	Exact identifier application number: NDA020533 ndc (package): 63323-288-07 ndc (package): 63323-288-06 ndc (package): 63323-285-02 ndc (package): 63323-286-23 ndc (package): 63323-287-21 ndc (package): 63323-285-20 ndc (package): 63323-286-00 ndc (package): 63323-285-07 ndc (package): 63323-288-11 ndc (package): 63323-286-09 ndc (package): 63323-285-63 ndc (package): 63323-287-20 ndc (package): 63323-286-20 ndc (package): 63323-287-01 ndc (package): 63323-285-57 ndc (package): 63323-286-35 ndc (package): 63323-286-31 ndc (package): 63323-288-01 ndc (package): 63323-285-23 ndc (package): 63323-285-01 ndc (package): 63323-286-30 ndc (package): 63323-288-20 ndc (package): 63323-288-03 ndc (package): 63323-285-06 ndc (package): 63323-287-03 ndc (package): 63323-286-03 ndc (package): 63323-285-51 ndc (package): 63323-286-11 ndc (package): 63323-285-10 ndc (package): 63323-285-13 ndc (package): 63323-286-33 ndc (package): 63323-286-01 ndc (package): 63323-285-65 ndc (package): 63323-285-03 ndc (package): 63323-285-61 ndc (package): 63323-285-64 ndc (package): 63323-285-04 ndc (package): 63323-286-05 ndc (package): 63323-288-10 ndc (package): 63323-288-21 ndc (package): 63323-286-63 ndc (product): 63323-288 ndc (product): 63323-285 ndc (product): 63323-287 ndc (product): 63323-286 rxcui: 1734348 rxcui: 905191 rxcui: 1734484 rxcui: 1734090 rxcui: 1734480 rxcui: 1734203 rxcui: 1734479 rxcui: 1734481 rxcui: 1734355 rxcui: 1734086 rxcui: 1734091 rxcui: 1734204 rxcui: 1734208 rxcui: 1734483 rxcui: 1734482 rxcui: 1734207 rxcui: 1734475 rxcui: 1734084 rxcui: 1734356 rxcui: 1734476 rxcui: 1734347 rxcui: 905189 spl id: cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9 spl set id: 23d2d448-a744-4877-9f2d-7e57c198da89 unii: V910P86109
Lymph/Spleen Combo	ADENOSINUM TRIPHOSPHORICUM DINATRUM, APIS MELLIFICA, CASTANEA VESCA, CEANOTHUS AMERICANUS, CHININUM ARSENICOSUM, FERRUM METALLICUM, HELIANTHUS ANNUUS, JUNIPERUS COMMUNIS, LYMPH NODE (SUIS), MYOSOTIS ARVENSIS, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, QUERCUS GLANDIUM SPIRITUS, SPLEEN (SUIS), SUCCINUM, THYMUS (SUIS), UBIDECARENONUM	Deseret Biologicals, Inc.	afce86e2-cbfa-44d4-b803-bc2ad5053357	2024-07-31	Warnings	Exact identifier unii: 451W47IQ8X
Lymph/Spleen Combo	JUNIPERUS COMMUNIS, QUERCUS GLANDIUM SPIRITUS, MYOSOTIS ARVENSIS, NATRUM SULPHURICUM, CEANOTHUS AMERICANUS, HELIANTHUS ANNUUS, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, LYMPH NODE (SUIS), SPLEEN (SUIS), THYMUS (SUIS), CHININUM ARSENICOSUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, UBIDECARENONUM, FERRUM METALLICUM, SUCCINUM, CASTANEA VESCA, APIS MELLIFICA	Deseret Biologicals, Inc.	b55787b5-5e35-4342-8f00-ef202c353877	2024-07-31	Warnings	Exact identifier unii: 451W47IQ8X
Adrenapar	ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM	Energique, Inc.	4080fcfb-7ef2-45f5-8c3b-592d3b66a120	2024-07-29	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Corporation	f55bd888-5e01-474d-871b-24654c070178	2024-07-24	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Sodium chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	83994d0c-8484-4505-abb5-8a384ed12288	2024-07-22	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
sodium chloride	SODIUM CHLORIDE	Becton Dickinson and Company	8df7dcf6-8714-6caf-e053-2995a90ab8cc	2024-07-15	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Naropin	ROPIVACAINE HYDROCHLORIDE	Fresenius Kabi USA, LLC	c6613708-c1f7-4f5c-91a3-ebbc1d7905c6	2024-07-10	Warnings, Adverse reactions	Exact identifier application number: NDA020533 ndc (package): 63323-285-55 ndc (package): 63323-288-29 ndc (package): 63323-286-93 ndc (package): 63323-285-67 ndc (package): 63323-286-95 ndc (package): 63323-288-23 ndc (product): 63323-288 ndc (product): 63323-285 ndc (product): 63323-286 ndc11 (package): 63323028555 rxcui: 1734348 rxcui: 1734484 rxcui: 1734090 rxcui: 1734480 rxcui: 1734203 rxcui: 1734479 rxcui: 1734481 rxcui: 1734355 rxcui: 1734086 rxcui: 1734091 rxcui: 1734204 rxcui: 1734208 rxcui: 1734483 rxcui: 1734482 rxcui: 1734207 rxcui: 1734475 rxcui: 1734084 rxcui: 1734356 rxcui: 1734476 rxcui: 1734347 spl id: 73218c89-8925-468c-84bf-9960b4b3dc3c spl set id: c6613708-c1f7-4f5c-91a3-ebbc1d7905c6 unii: V910P86109
Derma Pain Plus	CROTON TIGLIUM, NATRUM MURIATICUM, PLANTAGO MAJOR, RHUS TOXICODENDRON, SARSAPARILLA (SMILAX REGELII)	Peaceful Mountain, Inc.	6fa79c31-e48e-4c83-baa2-96cef22cfee1	2024-06-13	Warnings	Exact identifier unii: 451W47IQ8X
Cold Sore Rescue	BORAX, DULCAMARA, NATRUM MURIATICUM, RANUNCULUS BULBOSUS, SILICEA	Peaceful Mountain, Inc.	a7fe6ec7-a758-43cf-b46f-c327e0632fb8	2024-06-13	Warnings	Exact identifier unii: 451W47IQ8X
NATRUM MUR	NATRUM MUR	Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	1a22655a-68f3-4f13-e063-6294a90ae52c	2024-06-05	Warnings	Exact identifier unii: 451W47IQ8X
Mentox HP	AURUM METALLICUM, BARYTA CARBONICA, CALCAREA CARBONICA, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS	Energique, Inc.	ebb23637-4931-4563-ab30-99bea0276580	2024-05-28	Warnings	Exact identifier unii: 451W47IQ8X
Potassium Chloride in Lactated Ringers and Dextrose	POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE	Fresenius Kabi USA, LLC	dbed53b7-0109-4561-8342-0178ec8c64b0	2024-05-22	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Naropin	ROPIVACAINE HYDROCHLORIDE	Fresenius Kabi USA, LLC	56dfabf7-f7a8-4601-b17a-cb16fb995b0f	2024-05-22	Warnings, Adverse reactions	Exact identifier application number: NDA020533 ndc (product): 63323-288 rxcui: 1734090 rxcui: 1734086 rxcui: 1734091 rxcui: 1734084 spl id: 75465ceb-e894-487d-aa80-671fa0841fce spl set id: 56dfabf7-f7a8-4601-b17a-cb16fb995b0f unii: V910P86109
Lactated Ringers and Dextrose	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE	Fresenius Kabi USA, LLC	1b912c7e-f005-4af4-b683-083440964249	2024-05-22	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Sodium chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	239a5af1-7498-480f-862c-ab7c3d89d183	2024-05-21	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Sodium chloride	SODIUM CHLORIDE	Becton Dickinson and Company	ebc8b008-a8b3-4c41-89e4-b413f7aab89f	2024-05-21	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Allergies	APIS MELLIFICA, ECHINACEA, HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, ACONITUM NAPELLUS, AETHUSA CYNAPIUM, AGARICUS MUSCARIUS, ALETRIS FARINOSA, ALFALFA, ALLIUM CEPA, ALLIUM SATIVUM, AMBROSIA ARTEMISIAEFOLIA, ARSENICUM ALBUM, ARTEMISIA VULGARIS, ARUNDO MAURITANICA, AVENA SATIVA, BELLADONNA, BELLIS PERRENIS, BOVISTA, BROMIUM, BRYONIA, CAFFEINUM, CALCAREA CARBONICA, CALLUNA VULGARIS, FLOS, CAPSICUM ANNUUM, CAT HAIR, CHAMOMILLA, CHELIDONIUM MAJUS, CHENOPODIUM ANTHELMINTICUM, CINNAMOMUM	Newton Laboratories, Inc.	9d5dea47-5103-21a3-e053-2995a90aee78	2024-05-20	Warnings	Exact identifier unii: 451W47IQ8X
Colopar	COLON (SUIS), ARSENICUM ALBUM, CAUSTICUM, IGNATIA AMARA, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, SEPIA, SILICEA, THUJA OCCIDENTALIS	Energique, Inc.	c47d7203-abcd-4ae5-bf9b-5df07e07d3c1	2024-05-20	Warnings	Exact identifier unii: 451W47IQ8X
Aging Eye Formula	CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, GERMANIUM METALLICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, NATRUM MURIATICUM	Nutritional Specialties, Inc.	4510fe59-cc28-4585-925f-42508a60abd0	2024-05-13	Warnings	Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.